Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharma save search
Immutep’s Chinese Partner EOC Pharma to Start Phase II Metastatic Breast Cancer Study
Published: 2020-12-09 (Crawled : 23:01) - globenewswire.com
IMMP | $2.59 3.19% 3.09% 1.4M
|
Health Technology
|
| O: 224.54%
H: 13.41%
C: -18.83%
breast cancer chinese cancer pharma metastatic breast cancer
EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma
Published: 2020-12-21 (Crawled : 12:00) - globenewswire.com
EYEG | $34.815 -0.89% 5K
|
Health Technology
|
| O: 115.41%
H: 6.37%
C: -32.25%
acquisition eye pharma
Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc
Published: 2023-01-08 (Crawled : 20:20) - globenewswire.com
MC | $53.99 -1.12% 0.0% 840K
|
Finance
|
| O: 0.09%
H: 2.68%
C: 0.85%
AMYT | News | $14.7 0.0% 2.4M
|
Health Technology
|
| O: 106.53%
H: 0.0%
C: 0.0%
pharma acquire
Timber Pharmaceuticals to be Acquired by LEO Pharma
Published: 2023-08-21 (Crawled : 12:00) - globenewswire.com
TMBR | $0.3426 -2.69% 3K
|
Health Technology
|
| O: 104.23%
H: 10.34%
C: 3.1%
leo pharma pharmaceuticals acquired
Verona Pharma Announces Ensifentrine Meets Primary Endpoint in Phase 3 ENHANCE-2 Trial for COPD
Published: 2022-08-09 (Crawled : 07:00) - biospace.com/
VRNA | $15.21 -2.44% -2.5% 320K
|
Health Technology
|
| O: 101.29%
H: 5.0%
C: -28.31%
pharma trial
Verona Pharma Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-08-09 (Crawled : 08:00) - globenewswire.com
VRNA | $15.21 -2.44% -2.5% 320K
|
Health Technology
|
| O: 101.29%
H: 5.0%
C: -28.31%
pharma update results
HOOKIPA Pharma Announces $21.25 Million Equity Investment from Gilead Sciences
Published: 2023-12-21 (Crawled : 12:00) - globenewswire.com
HOOK | $0.843 10.2% 9.25% 10M
|
Health Technology
|
| O: 78.76%
H: 11.88%
C: -14.6%
pharma sciences
Midatech Pharma PLC Announces Breakthrough Data Using Q-Sphera Technology
Published: 2021-06-17 (Crawled : 08:00) - biospace.com/
MTP | $0.4703 -70.79% -73.69% 0
|
Health Technology
|
| O: 69.61%
H: 4.34%
C: -14.74%
technology pharma
Evoke Pharma Announces Approval of GIMOTI® to Florida State Medicaid Program
Published: 2022-06-15 (Crawled : 14:00) - biospace.com/
EVOK | $0.433 -2.37% -2.42% 9K
|
Health Technology
|
| O: 66.18%
H: 5.01%
C: -11.5%
gimoti pharma state program approval
Sonoma Pharmaceuticals and EMC Pharma Announce Department of Defense DAPA Registration for Microcyn(R) Rx Products
Published: 2023-01-25 (Crawled : 14:20) - biospace.com/
SNOA | $0.155 -2.52% -2.58% 120K
|
Health Technology
|
| O: 65.83%
H: 34.67%
C: -15.08%
pharmaceuticals pharma defense
Nutra Pharma Expands Manufacturing Capabilities
Published: 2022-03-17 (Crawled : 13:30) - globenewswire.com
NPHC | $0.0001 2900.0% 3
|
Manufacturing
|
| O: 54.55%
H: 0.0%
C: 0.0%
expansion pharma
Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader
Published: 2022-04-13 (Crawled : 11:00) - biospace.com/
HALO M | $39.095 0.32% 0.32% 620K
|
Health Technology
|
| O: 0.29%
H: 1.2%
C: -0.67%
ATRS | $5.59 0.0%
|
Health Technology
|
| O: 48.53%
H: 0.63%
C: 0.45%
pharma drug
Inozyme Pharma Reports Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701
Published: 2023-02-16 (Crawled : 14:00) - globenewswire.com
INZY | $4.4 0.0% 480K
|
Health Technology
|
| O: 45.05%
H: 5.28%
C: -16.15%
inz-701 ongoing pharma trials topline positive phase 1
Zosano Pharma Requests Type A Meeting with the FDA to Review Resubmission Plans for Qtrypta™ New Drug Application
Published: 2021-01-04 (Crawled : 22:01) - globenewswire.com
ZSAN | $0.5576 7.23% -5.85%
|
Health Technology
|
| O: 44.26%
H: 25.0%
C: -4.15%
drug fda submission new drug application resubmission pharma
Silo Pharma Announces Positive Study Results of SPU- 21 for Arthritis
Published: 2022-12-30 (Crawled : 13:20) - globenewswire.com
SILO | $1.9 6.74% 6.32% 380K
|
Finance and Insurance
|
| O: 41.81%
H: 35.26%
C: -30.72%
pharma positive study
Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma
Published: 2024-01-07 (Crawled : 20:20) - globenewswire.com
VINC | $0.9392 -1.14% -1.15% 460K
|
|
| O: 38.56%
H: 4.59%
C: -16.82%
pharma
Royalty Pharma Acquires Royalty Interest in Seltorexant From Minerva Neurosciences
Published: 2021-01-19 (Crawled : 14:01) - globenewswire.com
RPRX | $27.98 0.58% 0.57% 1.8M
|
Health Technology
|
| O: 1.06%
H: 1.39%
C: -1.24%
NERV | $2.53 0.0% 3.9K
|
Health Technology
|
| O: 34.69%
H: 2.74%
C: -5.48%
pharma
60 Degrees Pharma Announces IRB Approval of Phase IIA Study to Evaluate Tafenoquine for Babesiosis, an Emerging Tick-Borne Disease; Type C Meeting Re-Scheduled by FDA to January 17, 2024
Published: 2023-12-26 (Crawled : 13:00) - globenewswire.com
SXTP | $0.2506 -2.45% 130K
|
n/a
|
| O: 33.08%
H: 27.5%
C: -3.75%
fda pharma approval meeting study
Midatech Pharma PLC Announces Fast Track Designation for MTX110 Development
Published: 2022-06-01 (Crawled : 12:20) - biospace.com/
MTP | $0.4703 -70.79% -73.69% 0
|
Health Technology
|
| O: 30.75%
H: 9.26%
C: -8.95%
mtx110 designation pharma fast track designation
Myovant Sciences Special Committee of Board Confirms Receipt of Preliminary, Non-binding Proposal from Sumitovant Biopharma and Sumitomo Pharma to Acquire Remaining Shares
Published: 2022-10-02 (Crawled : 00:00) - globenewswire.com
MYOV | $26.98 -0.04% 0.0% 0
|
Health Technology
|
| O: 29.48%
H: 6.37%
C: 3.82%
biopharma pharma sciences acquire proposal
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.